Clinical trial · Observational
Health Outcomes and Costs (HOC) in Lung Cancer (LC)
Health Outcomes and Costs (HOC) in Brazilian Public Health Care System - The HOC Study in Lung Cancer
NCT02363101CI-TRIAL-00016990HOC-LCunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the costs, health-related quality of life and preference values from lung cancer patients assisted in a Brazilian public health care unit.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Direct costs
- timeFrame
- one year
- description
- Direct costs related to each procedure involved on lung cancer
- measure
- HRQoL
- timeFrame
- up to 30 days after the procedure
- measure
- Preference values
- timeFrame
- cross sectional
- description
- Evaluate preference values in hypothetic scenarios
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical diagnosis of lung cancer disease * Able to understand the overall concept of study and sign the written informed consent Exclusion Criteria: * Illiterate * Visible cognitive impaired * Non-primary lung tumor
References
Publications (0)
Data not yet available
No reference posted for this study.